Side-by-side comparison

NVO vs SNY — Side-by-side comparison

Neither screens cheaper on EV/FCF, Neither has the higher ROIC, Neither has grown revenue faster over five years, and Neither has the cleaner balance sheet by net debt / EBITDA.

NVO

Novo Nordisk A S

Price

$44.96

Market cap

$305.8B

Day %

N/A

SNY

Sanofi Aventis

Price

$44.29

Market cap

$133.3B

Day %

N/A

Peer Comparison

Target stock against 1 market-cap comparable peer.

Heat map: red worst to green best


NVO Target	Novo Nordisk A S	$305.8B	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SNY	Sanofi Aventis	$133.3B	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

NVO implied-growth snapshot

Simple static valuation context using owner earnings yield and realized growth.

EV/FCF

N/A

FCF yield

N/A

5Y rev CAGR

N/A

SNY implied-growth snapshot

Simple static valuation context using owner earnings yield and realized growth.

EV/FCF

N/A

FCF yield

N/A

5Y rev CAGR

N/A

5Y indexed stock chart

Static Recharts view indexed to 100 from available annual per-share data.

Quality Scorecard

Build-time composite score for NVO.

Grade F

/ 100

Quality Scorecard

Build-time composite score for SNY.

Grade F

/ 100